NO993465D0 - Adenovirus-vektor-formidlet gen transport inn i modullaere motoriske neuroner - Google Patents

Adenovirus-vektor-formidlet gen transport inn i modullaere motoriske neuroner

Info

Publication number
NO993465D0
NO993465D0 NO993465A NO993465A NO993465D0 NO 993465 D0 NO993465 D0 NO 993465D0 NO 993465 A NO993465 A NO 993465A NO 993465 A NO993465 A NO 993465A NO 993465 D0 NO993465 D0 NO 993465D0
Authority
NO
Norway
Prior art keywords
mediated gene
adenovirus vector
motor neurons
modular motor
gene transport
Prior art date
Application number
NO993465A
Other languages
English (en)
Other versions
NO993465L (no
Inventor
Francoise Finiels
Minerva Gimenez-Ribotta
Jacques Mallet
Alain Privat
Fruduric Revah
Original Assignee
Rhone Poulenc Rorer Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/785,074 external-priority patent/US6632427B1/en
Application filed by Rhone Poulenc Rorer Sa, Inst Nat Sante Rech Med filed Critical Rhone Poulenc Rorer Sa
Publication of NO993465D0 publication Critical patent/NO993465D0/no
Publication of NO993465L publication Critical patent/NO993465L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO993465A 1997-01-17 1999-07-14 Adenoviral-vektor-formidlet gentransport inn i medulaere motoriske neuroner NO993465L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/785,074 US6632427B1 (en) 1994-12-13 1997-01-17 Adenoviral-vector-mediated gene transfer into medullary motor neurons
US4224797P 1997-03-31 1997-03-31
PCT/EP1998/000220 WO1998031395A1 (en) 1997-01-17 1998-01-16 Adenoviral-vector-mediated gene transfer into medullary motor neurons

Publications (2)

Publication Number Publication Date
NO993465D0 true NO993465D0 (no) 1999-07-14
NO993465L NO993465L (no) 1999-09-09

Family

ID=26719029

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993465A NO993465L (no) 1997-01-17 1999-07-14 Adenoviral-vektor-formidlet gentransport inn i medulaere motoriske neuroner

Country Status (11)

Country Link
US (1) US6552003B2 (no)
EP (1) EP0969875B1 (no)
JP (1) JP2002516607A (no)
AU (1) AU6614398A (no)
BR (1) BR9806912A (no)
CA (1) CA2277869A1 (no)
CZ (1) CZ250499A3 (no)
IL (1) IL130852A0 (no)
NO (1) NO993465L (no)
SK (1) SK95599A3 (no)
WO (1) WO1998031395A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2277528E (pt) * 2000-04-12 2015-02-05 Life Sciences Res Partners Vzw Uso de vegf e homólogos para tratar doenças do neurónio
WO2003004660A1 (en) * 2001-07-03 2003-01-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of administering vectors to synaptically connected neurons
CA2469658A1 (en) * 2001-12-19 2003-07-03 Lijun Wang Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
EP1708756A2 (en) * 2003-12-12 2006-10-11 Wisconsin Alumni Research Foundation Treatment of mammals by sirna delivery into mammalian nerve cells
CA2568158A1 (en) 2004-05-27 2005-12-15 D. Collen Research Foundation Vzw Treatment of amyotrophic lateral sclerosis
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
WO2021163274A1 (en) * 2020-02-11 2021-08-19 The General Hospital Corporation Methods for treating amyotrophic lateral sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
GR1000980B (el) * 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
FR2727867B1 (fr) * 1994-12-13 1997-01-31 Rhone Poulenc Rorer Sa Transfert de genes dans les motoneurones medullaires au moyen de vecteurs adenoviraux
WO1997039629A1 (en) * 1996-04-25 1997-10-30 Genetic Therapy, Inc. Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor

Also Published As

Publication number Publication date
EP0969875B1 (en) 2008-11-26
US20020164303A1 (en) 2002-11-07
JP2002516607A (ja) 2002-06-04
EP0969875A1 (en) 2000-01-12
AU6614398A (en) 1998-08-07
CZ250499A3 (cs) 1999-11-17
IL130852A0 (en) 2001-01-28
SK95599A3 (en) 2000-05-16
US6552003B2 (en) 2003-04-22
BR9806912A (pt) 2000-05-16
CA2277869A1 (en) 1998-07-23
NO993465L (no) 1999-09-09
WO1998031395A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
FI970388A (fi) Menetelmä kuvasekvenssien kontrastin parantamiseksi
DE59909272D1 (de) Frachtladesystem
FI971022A (fi) Konttisekoitin
ZA982793B (en) Side-flexing conveyor construction
DE59802359D1 (de) Transportsystem
FI961666A0 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
NO993465D0 (no) Adenovirus-vektor-formidlet gen transport inn i modullaere motoriske neuroner
DE59810608D1 (de) Stapelvorrichtung
IT237535Y1 (it) Rampa di carico perfezionata
AU4116597A (en) Transport pallet
IT243205Y1 (it) Paletta salva spazio
DK1036009T3 (da) Palle
FI973333A0 (fi) Underlag i en jaernvaegsvagn foer transport av spolar
KR970038743U (ko) 팰릿
NO973129D0 (no) Transportbeholder
FI3013U1 (fi) Polttoaineen kuljetusvaunu
KR970036600U (ko) 계단용 전동식 화물운반장치
FI3457U1 (fi) Kuljetuskärry
KR970038744U (ko) 팰릿
IT1294694B1 (it) Elevatore autocarrato
SE9702136D0 (sv) Lås för vattenpost
PL320262A1 (en) Transportation platform
FI2963U1 (fi) Ajoneuvotähtäin
NO20000525D0 (no) Kombinert transportoer
FI971146A0 (fi) Vindkraftverk och foerfarande foer transport och uppmontering daerav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application